Inframalleolar venous ulcers heal with Unna boot therapy Authors: Camille L. Karren, Nisha D.S. Gill-Jones, Justin M. Robbins, Enrico Ascher, Alexandra N. Ascher, Anil Hingorani Published: 2026 ABSTRACT BackgroundThis study highlights the presentation of inframalleolar ulcers in venous disease, their wound healing factors, recurrence rate, and response to Unna boot treatment with adjunct endovenous and/or iliac vein stenting treatments.MethodsThis retrospective single-center study included 71 office-based patients with inframalleolar venous ulcers treated between May 2012 and May 2023. Of the 71 patients evaluated, 12 presented with bilateral ulcers, resulting in a total of 83 limbs treated. Patient demographics including age, sex, ulcer etiology, ulcer location, diabetes status, and treatment modality were evaluated. All patients presented with bilateral leg swelling and venous reflux greater than 500 ms suggestive of venous insufficiency. Initially, patients were required to have palpable pedal pulses and a normal ankle-brachial index (ABI) for inclusion. Over time, inclusion criteria were broadened to accept patients with mixed arterial venous disease, provided their ABI was greater than 0.6. Patients with isolated arterial pathology and an ABI <0.6 and those with diabetic neuropathic ulcer etiology were excluded from this study. Patients received compression therapy that included an elastic all-cotton elastic wrap and an inelastic Unna boot formulated with calamine, zinc oxide, and glycerin, both applied by trained medical assistants. Sixty-five patients received additional endovenous and/or iliac vein stenting treatments.ResultsThe mean patient age was 67 ± 14 years (range, 25-96 years). Of the 71 patients treated, 12 (16.9%) presented with ulcers on both limbs, resulting in a total of 83 limbs treated. All ulcers were treated with weekly Unna boots, with an average treatment duration of 12 ± 23 weeks (range, 1-181 weeks) and a median treatment duration of 5 weeks. After wound healing, patients were followed for a mean duration of 16 ± 28 months. The success rate of >90% healing for inframalleolar ulcers was 51.8%. Factors associated with wound healing were ulcers that were primarily venous in nature as opposed to mixed (P = .01). Heel ulcers were not associated with inferior wound healing (P = .10) compared with other locations but were associated with higher rates of recurrence (P = .002). In total, 26.76% of patients had recurrent ulcers, whereas 45.13% did not; 8.4% of ulcers were still actively being treated with Unna boots, and 19.71% of patients were lost to follow-up. Improved healing of inframalleolar ulcers was significantly associated with the presence of a concomitant supramalleolar ulcer on the same limb (P = .02).ConclusionsThis study brings attention to the uncommon presentation of inframalleolar ulcers in venous stasis disease and is driven by the observation that bilateral leg swelling can lead to poor wound healing. Compression therapy using Unna boots is easily accessible, cost-effective, and should be considered as it offers significant therapeutic benefit in this patient population. Article Highlights •Type of Research: Single-center retrospective cohort study•Key Findings: The success rate of >90% healing for limbs with inframalleolar ulcers only was 51.8%. Among patients with supramalleolar and inframalleolar ulcers on the same limb, the success rate of healing (>90%) was 54.5%.•Take Home Message: It is important in clinical practice to routinely assess the venous origin of inframalleolar ulcers as a potential contributing etiology, as compression therapy in addition to endovenous and/or iliac vein stenting treatments may benefit this patient population by augmenting lower-extremity swelling. Article Highlights •Type of Research: Single-center retrospective cohort study•Key Findings: The success rate of >90% healing for limbs with inframalleolar ulcers only was 51.8%. Among patients with supramalleolar and inframalleolar ulcers on the same limb, the success rate of healing (>90%) was 54.5%.•Take Home Message: It is important in clinical practice to routinely assess the venous origin of inframalleolar ulcers as a potential contributing etiology, as compression therapy in addition to endovenous and/or iliac vein stenting treatments may benefit this patient population by augmenting lower-extremity swelling. •Type of Research: Single-center retrospective cohort study Type of Research: Single-center retrospective cohort study •Key Findings: The success rate of >90% healing for limbs with inframalleolar ulcers only was 51.8%. Among patients with supramalleolar and inframalleolar ulcers on the same limb, the success rate of healing (>90%) was 54.5%. Key Findings: The success rate of >90% healing for limbs with inframalleolar ulcers only was 51.8%. Among patients with supramalleolar and inframalleolar ulcers on the same limb, the success rate of healing (>90%) was 54.5%. •Take Home Message: It is important in clinical practice to routinely assess the venous origin of inframalleolar ulcers as a potential contributing etiology, as compression therapy in addition to endovenous and/or iliac vein stenting treatments may benefit this patient population by augmenting lower-extremity swelling. Take Home Message: It is important in clinical practice to routinely assess the venous origin of inframalleolar ulcers as a potential contributing etiology, as compression therapy in addition to endovenous and/or iliac vein stenting treatments may benefit this patient population by augmenting lower-extremity swelling. Lower-extremity wounds are predominately classified into four categories: venous, arterial, diabetic, and pressure ulcers. This categorization, often based on the location, depth, appearance, and clinical examination, facilitates a comprehensive approach to diagnosis and treatment recommendations for most chronic wounds.1,2 In chronic wounds, venous ulcers are the most prevalent,3 typically manifesting as shallow lesions in the malleolar region of the lower extremity exhibiting irregularity and shallowness with well-defined borders on physical examination. In contrast, arterial ulcers are mostly associated with lesions on the foot and may have exposed tendons or bones.3 Current clinical practice, however, has identified presentations of venous ulcers that deviate from these previously accepted descriptions. Although many sources continue to identify venous ulcers as those located in the malleolar region and arterial ulcers as those located in the inframalleolar region,4 clinicians are finding inframalleolar ulcers with a component of venous insufficiency. The clinical consequences of venous disease extend beyond local wound complications, as population-based studies have shown that deep venous disease and venous leg ulcerations are associated with increased morbidity and mortality.5 This study aims to highlight the distinction to improve the diagnosis and treatment of venous ulcers with this presentation. The patients in our study initially presented with inframalleolar, dorsal, toe, and plantar ulcers, with lower-extremity edema, palpable pedal pulses, and no significant arterial disease component. Treatment was eventually extended to include patients with an arterial component combined with venous disease, provided their ankle-brachial index (ABI) was greater than 0.6. If a patient presented with severe components of arterial insufficiency and an ABI < 0.6, they were not treated with compression therapy. All the patients presented at onset with bilateral leg swelling and duplex findings suggestive of venous insufficiency with superficial venous reflux greater than 500 ms or deep venous reflux greater than 1 second.6 Given this presentation and associated lower-extremity edema, tailored treatment with weekly Unna boot compression could be used, resulting in wound healing and improved patient outcomes.1,7,8 This study sought to evaluate our center's experience with patients presenting with uncommon inframalleolar ulcers and their response to Unna boot treatment and endovenous procedures. Highlighting this presentation and appropriate treatment methods could lead to improved diagnosis, treatment, and outcomes in patients with a similar presentation. Methods This retrospective, single-center study evaluated 71 office-based patients with inframalleolar venous ulcers from May 2012 to May 2023. Of the 71 patients evaluated, 12 presented with bilateral ulcers, resulting in a total of 83 limbs treated. A single practitioner performed a full physical examination, evaluated pedal pulses in each patient, and performed appropriate arterial and venous imaging, including duplex ultrasound study, to confirm ulcer origin. If pedal pulses were not palpable, an ABI test was performed by the same practitioner and recorded in the affected limb. ABI testing was not routinely performed in patients with bilateral lower-extremity edema, venous insufficiency, and palpable pulses on physical examination. Patients with underlying arterial disease did not undergo treatment with Unna boot compression if the ABI was 0.6 or less (grade 2, level C evidence), as recommended by the Society for Vascular Surgery (SVS) and American Venous Forum (AVF) guidelines.9 They received an arterial duplex followed by arterial vascularization and were excluded from the study. Patient history and location on physical examination were used for categorizing diabetic foot ulcers. Ulcers consistent with a diabetic neuropathic etiology, commonly located over plantar bony prominences, were excluded from analysis. All patients included in the study presented with bilateral leg swelling and duplex findings suggestive of venous insufficiency, with superficial venous reflux greater than 500 ms or deep venous reflux greater than 1 second in the superficial and deep veins. Initially treatment began in patients with palpable pedal pulses or a normal ABI. Treatment was eventually extended to include patients with an arterial component in combined arterial venous disease, provided their ABI was greater than 0.6. Simple manual measurement with a ruler was used to obtain the height and width of the ulcer at its greatest extent in the respective directions. If multiple ulcers were present on the same limb, only the largest ulcer was measured and included in the dataset. The ulcers were washed with normal saline before weekly application of an elastic all-cotton elastic wrap and an inelastic Unna boot, formulated with calamine, zinc oxide, and glycerin, performed by trained medical assistants. Ulcer debridement was not performed before compression therapy given the limited subcutaneous tissue in the foot and the proximity of exposed bone, tendons, and ligaments. Of the 71 patients treated with Unna boot therapy, 42 patients underwent iliac vein stenting procedures and 23 patients underwent additional procedures including Varithena foam sclerotherapy (Boston Scientific) (n = 5), physician-compounded sclerotherapy (n = 4), endovenous radiofrequency ablations (Closefast, Medtronic) (n = 9), and endovenous laser ablations (VenaCure, Angiodynamics) (n = 11) in the great saphenous veins, small saphenous veins, accessory saphenous veins, and saphenous vein tributaries, including varicose veins. No concomitant procedures were performed on venous tributaries. Ulcer height and width were compared at the beginning and end of treatment, and recurrence rates were evaluated. Information on the patients and their ulcers were broken down into various categories, including age, sex, etiology (venous or mixed), ulcer location (such as toe, plantar, dorsal, heel, and others), presence of diabetes as a comorbidity, and treatment modality (Unna boot alone or in combination with another technique). These factors were analyzed using χ2 tests in Microsoft Excel (version 16.0.17230.42306; Microsoft Corporation) to determine whether they played a significant role in the wound healing of inframalleolar ulcers. A P value of less than .05 was considered statistically significant. The primary end point was complete/near-complete wound healing, as defined by the authors as an area reduction of 90% or more. The secondary end point for this study was to determine factors associated with inframalleolar wound healing and recurrence. Institutional review board approval was obtained retrospectively to collect data for our venous registry. Consent was waived by the institutional review board given the retrospective nature of this study, minimal risks to participants, and deidentification of patient data. Data collection and interpretation conformed with the principles set by the Declaration of Helsinki. Results Of the 71 patients evaluated, 12 presented with bilateral ulcers, resulting in a total of 83 limbs treated. These were taken from a set of 4707 limbs with venous leg ulcers treated from May 2012 to May 2023. Of the 83 limbs examined, there were 64 limbs with venous ulcers and 19 limbs with mixed (arterial and venous) ulcers. Nineteen patients presented with concomitant supramalleolar ulcers on the same limb. The mean age of this patient population was 67 ± 14 years (range, 25-96 years). The cohort included 39 male and 32 female patients. Diabetes mellitus was present in 39 patients and absent in 32. Baseline demographic information is summarized in Table I. Although the primary focus of our study was inframalleolar ulcers, 19 patients presented with concomitant supramalleolar and inframalleolar ulcers on the same limb, whereas 52 patients had inframalleolar ulcers alone. Of the 19 patients with concomitant ulcers, 3 had bilateral involvement, resulting in a total of 22 limbs treated.Table IPatient demographics, limb characteristics, and treatmentsPatient demographicsN (71)Age—mean ± SD67 ± 14Female32Male39Diabetic patient39Nondiabetic patient32Total No. of ulcerated limbsN (83)aPatients with bilateral limb ulcers12Limbs characteristics Venous ulcers64 Mixed venous and arterial19 Toe ulcers22 Plantar ulcers8 Dorsal ulcers27 Heel ulcers9 Ulcers in locations not defined above17Patient treatments Unna boot71Additional treatments of limbsn (65)bVarithena foam sclerotherapy5Physician-compounded sclerotherapy4Endovenous radiofrequency ablations9Endovenous laser ablations11Iliac vein stenting42aOf the 71 patients treated, 12 patients had inframalleolar ulcers present on both limbs, resulting in a total of 83 limbs treated.bOf the 24 patients who were treated with additional therapies, six patients were treated with one or more of those procedures in one or both limbs. Table IPatient demographics, limb characteristics, and treatmentsPatient demographicsN (71)Age—mean ± SD67 ± 14Female32Male39Diabetic patient39Nondiabetic patient32Total No. of ulcerated limbsN (83)aPatients with bilateral limb ulcers12Limbs characteristics Venous ulcers64 Mixed venous and arterial19 Toe ulcers22 Plantar ulcers8 Dorsal ulcers27 Heel ulcers9 Ulcers in locations not defined above17Patient treatments Unna boot71Additional treatments of limbsn (65)bVarithena foam sclerotherapy5Physician-compounded sclerotherapy4Endovenous radiofrequency ablations9Endovenous laser ablations11Iliac vein stenting42aOf the 71 patients treated, 12 patients had inframalleolar ulcers present on both limbs, resulting in a total of 83 limbs treated.bOf the 24 patients who were treated with additional therapies, six patients were treated with one or more of those procedures in one or both limbs. Patient demographics, limb characteristics, and treatments Of the 71 patients treated, 12 patients had inframalleolar ulcers present on both limbs, resulting in a total of 83 limbs treated. Of the 24 patients who were treated with additional therapies, six patients were treated with one or more of those procedures in one or both limbs. Venous ulcers, as opposed to mixed etiology, were significantly associated with wound healing (P =.01). Factors that were not associated with wound healing were sex (P = .46), age (P = .61), diabetes as a comorbidity (P = .46), and ulcer location (P = .63 for dorsal ulcers, P = .39 for plantar ulcers, P = .10 for heel ulcers, and P = .84 for toe ulcers) (Table II). In addition, whether a limb had an additional procedure, such as Varithena foam sclerotherapy, physician-compounded sclerotherapy, endovenous radiofrequency ablations, endovenous laser ablations, or iliac vein stenting, was not associated with better wound healing (P = .62) (Table I).Table IIDemographics stratified by wound healing with treatmentDemographicsHealedNot healedPMale2520.46Female1820–Age >65 years2521.61Age <65 years1819–Venous3826.01Combined514–Diabetic1719.46Nondiabetic patients2621– Table IIDemographics stratified by wound healing with treatmentDemographicsHealedNot healedPMale2520.46Female1820–Age >65 years2521.61Age <65 years1819–Venous3826.01Combined514–Diabetic1719.46Nondiabetic patients2621– Demographics stratified by wound healing with treatment All ulcers were treated with weekly Unna boots, with an average treatment duration of 12 ± 23 weeks (range, 1-181 weeks) and a median treatment duration of 5 weeks. After wound healing, patients were followed for a mean duration of 16 ± 28 months (range, 0-72 months). Table III presents the average ulcer height and width of the total sample and changes in ulcer height and width after therapy. The success rate of >90% healing in limbs with inframalleolar ulcers only was 51.8%. Among patients with supramalleolar and inframalleolar ulcers on the same limb, the success rate of healing (>90%) was 54.5%. Improved healing of inframalleolar ulcers was not significantly associated with the presence of a concomitant supramalleolar ulcer on the same limb (P = .88). Among all inframalleolar ulcerated limbs (n = 83), including both isolated inframalleolar ulcers and those occurring with concomitant supramalleolar ulcers on the same limb, 25.3% (21/83) of the ulcers healed by <50%, 8.4% (7/83) healed by 51% to 70%, 14.5% (12/83) healed by 71% to 89%, and 51.8% (43/83) of the ulcers healed by 90% or more. Fig demonstrates two images of an isolated inframalleolar venous ulcer at the beginning and end of treatment with Unna boot compression therapy.Table IIIChange in ulcer sizeBefore therapy (mean ± SD)After therapy (mean ± SD)Total sample Height2.64 ± 2.051.28 ± 1.96 Width2.60 ± 1.981.12 ± 1.71Healed >90% Height2.34 ± 1.450.18 ± 0.41 Width2.22 ± 1.700.15 ± 0.37SD, Standard deviation.FigInframalleolar venous ulcer pre- and posttreatment. Written informed consent was obtained from the patient for the publication of this case report and accompanying images. Table IIIChange in ulcer sizeBefore therapy (mean ± SD)After therapy (mean ± SD)Total sample Height2.64 ± 2.051.28 ± 1.96 Width2.60 ± 1.981.12 ± 1.71Healed >90% Height2.34 ± 1.450.18 ± 0.41 Width2.22 ± 1.700.15 ± 0.37SD, Standard deviation. Change in ulcer size SD, Standard deviation. Inframalleolar venous ulcer pre- and posttreatment. Written informed consent was obtained from the patient for the publication of this case report and accompanying images. During a mean follow-up of 16 ± 28 months, 26.76% of patients had recurrence, 45.13% remained recurrence-free, and 19.71% were lost to follow-up. At the time of data collection, 8.4% (n = 7) of ulcers were still actively being treated with Unna boots. Factors not associated with recurrence rates were sex (P = .28), age (P = .86), diabetes as a comorbidity (P = .39), toe ulcers (P = .19), dorsal ulcers (P = .59), plantar ulcers (P = .16), and additional procedures (P = .25). Heel ulcers were not associated with inferior wound healing (P = .10) compared with other locations but were associated with higher rates of recurrence (P = .002). Several patients who achieved >90% wound healing did not return for further in-office evaluation because complete healing occurred the following week. Healing status was confirmed by telephone follow-up. On average, ulcers recurred at 3.9 ± 6.2 months (range, 0.23-22.7 months). The average duration of recurrence was 22 ± 38 weeks (range, 1-181 weeks). In comparison, inframalleolar ulcers had a recurrence rate of 21.31% (n = 13), with an average duration of 12 ± 23 weeks. Concomitant supramalleolar ulcers had a significantly higher recurrence rate of 68.2% (n = 15) compared with those of limbs with isolated inframalleolar ulcers (P ≤ .001). Discussion Our study highlights the prevalence of inframalleolar ulcers with a component of venous insufficiency and their promising results when treated with Unna boot compression therapy alone and in combination with endovenous procedures. This presentation differs from the classic description of perimalleolar venous stasis ulcers and from inframalleolar ulcers of arterial or diabetic origin. Although there have been reports regarding inframalleolar ulcers in venous disease, to our knowledge, we believe this is the largest reported series. It is an important topic to discuss for practitioners who are not as facile with this presentation. Initially treatment began in patients with palpable pedal pulses and normal ABI. Treatment was eventually extended to include patients with an arterial component in combined arterial venous disease, provided their ABI was greater than 0.6. If a patient presented with severe components of arterial insufficiency and an ABI < 0.6, compression therapy was withheld. Patient history and ulcer location on physical examination were used to classify diabetic foot ulcers. Ulcers consistent with diabetic etiology were excluded from analysis and were not treated with compression therapy. In addition, lower-extremity edema was not considered a pathologic finding of diabetic neuropathic ulcers. Edema is known to significantly impair wound healing by compromising tissue perfusion, increasing local pressure, and delaying epithelialization.8 All patients in our study presented with bilateral leg swelling; therefore, Unna boot compression therapy was used to reduce the swelling and augment the wound healing process because it is recommended by the clinical practice guidelines of the SVS and AVF (grade 1, level A evidence).9 Unna boot compression is accessible, cost-effective, and can be easily applied in an outpatient setting. These factors combined with its therapeutic benefit in reducing swelling make it an appropriate treatment for patients with inframalleolar ulcers due to venous stasis disease.7 When treating mixed ulcers with compression, edema is reduced, which augments wound healing in these patients. The patients treated in this study had ABI ≥0.6, adequate perfusion, and no presentation of severe arterial insufficiency. Since these patients did not have a severe arterial component in their mixed ulcer presentation, compression therapy should not have a significant effect on their arterial supply and promoted tissue repair. Wound healing was achieved in inframalleolar ulcers with a component of venous insufficiency after treatment with Unna boot compression therapy. However, no difference was observed in wound healing compared with ulcerated limbs by age, sex, ulcer location, diabetes as a comorbidity, and use of additional treatment modality. Previous studies have highlighted the efficacy of Unna boot compression therapy for treating classic perimalleolar venous ulcers.10 These findings draw attention to the prevalence of inframalleolar ulcers of venous origin and the importance of assessing venous origin in inframalleolar ulcers during clinical practice to promote wound healing with the use of compression therapy. The clinical practice guidelines by the SVS and the AVF on the management of venous leg ulcers state that the standard definition of a venous ulcer is “an open skin lesion of the leg or foot that occurs in an area affected by venous hypertension.”9 However, despite this definition, many sources continue to identify venous ulcers as those located in the malleolar region and diabetic or arterial ulcers as those located in the inframalleolar region.4 This study aims to highlight the significance of inframalleolar ulcers of venous origin, with the goal of transforming the way venous ulcers are recognized and treated to improve outcomes and decrease delays in appropriate care. Future research efforts are needed as there are several limitations to this study. One limitation is this was a retrospective, single-center study whose population was preselected in terms of comorbid factors. As it was intended as a descriptive study based on retrospectively collected data from a series of patients we noted, a formal sample size calculation was not applicable. Another limitation to consider is our patient population characteristics. Patients selected for treatment in our study presented with edema in their lower extremities and were excluded if severe arterial insufficiency (nonpalpable pulses with ABI levels < 0.6) was suspected. Although all patients treated in our study had venous reflux, not all reflux was corrected. We routinely suggest fixing sources of venous reflux because of its association with faster rates of healing and decreased recurrence rates.11 Ablation and/or stenting were offered uniformly to each patient; however, some of our patients declined. This component of patient preference and refusal of treatment makes it difficult to separate the effects of ablation and/or stenting from Unna boot treatment alone, which should be addressed in subsequent studies. Another limitation includes the number of patients lost to follow-up due to the continuous weekly treatment requirement when using an Unna boot. If the patient had an appointment and they do not show up the next week, we called them to determine why they did not show up. We also did not have a control group in our study for comparison, which is a future route of exploration. A final important limitation of this study was that ABIs were not routinely checked in patients with easily palpable pedal pulses. In addition, the implementation of an ABI cutoff later in the study introduced a change in exclusion criteria over time, potentially creating two distinct patient groups with differing baseline vascular assessments. As a result, we were unable to record an average ABI for the overall population or to compare ABI values between patients whose ulcers healed and those whose ulcers did not heal. Routine ABI assessment for all patients in future studies would allow for a more comprehensive evaluation of baseline arterial perfusion and its relationship to wound healing outcomes, while also ensuring consistency in inclusion criteria across the study period. Considering these limitations, future multicenter studies could aim to determine the prevalence of inframalleolar ulcers in a larger group of patients from both ambulatory and inpatient settings. The present and future studies may present opportunities for improved outcomes in patients presenting with inframalleolar ulcers. Conclusions Venous stasis ulcers are classically located in the perimalleolar region of the lower extremity but can present in the inframalleolar area. Inframalleolar ulcers are part of the spectrum of presentations for venous leg ulcers. Having a primarily venous ulcer, rather than a mixed ulcer, was associated with improved wound healing rates of 90% or more when treated with Unna boot in combination with additional treatments. These findings show venous stasis disease should be considered as a possible contributing etiology for patients presenting with inframalleolar ulcers, and compression therapy could be beneficial in treating this patient population by augmenting lower-extremity swelling. Additional studies are warranted to better examine the therapeutic effects of Unna boot compression in inframalleolar ulcers of venous disease to educating providers unfamiliar with this presentation on improved diagnosis, treatment, and outcomes. Author Contributions Conception and design: NGJ, JR, EA, AA, AH Analysis and interpretation: CK, NGJ, JR, EA, AA, AH Data collection: CK, NGJ, JR, EA, AA, AH Writing the article: CK, NGJ, JR, AH Critical revision of the article: CK, NGJ, JR, EA, AA, AH Final approval of the article: CK, NGJ, JR, EA, AA, AH Statistical analysis: CK, NGJ, JR Obtained funding: Not applicable Overall responsibility: CK, JR Funding None. Disclosures None.